Lars Køber to Percutaneous Coronary Intervention
This is a "connection" page, showing publications Lars Køber has written about Percutaneous Coronary Intervention.
Connection Strength
1.475
-
A More COMPLETE Picture of Revascularization in STEMI. N Engl J Med. 2019 10 10; 381(15):1472-1474.
Score: 0.240
-
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. J Am Heart Assoc. 2018 05 18; 7(11).
Score: 0.219
-
Complete Revascularization in ST-Elevation Myocardial Infarction? N Engl J Med. 2017 03 30; 376(13):1282-1284.
Score: 0.202
-
Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy. EuroIntervention. 2019 Jun 20; 15(2):172-179.
Score: 0.059
-
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. JACC Cardiovasc Interv. 2019 04 22; 12(8):721-730.
Score: 0.058
-
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J. 2019 01 07; 40(2):180-186.
Score: 0.057
-
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Interv. 2018 09; 11(9):e006842.
Score: 0.056
-
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy. EuroIntervention. 2018 Aug 20; 14(6):700-707.
Score: 0.056
-
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study. Am Heart J. 2018 10; 204:128-138.
Score: 0.056
-
Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients. Am J Cardiol. 2018 10 15; 122(8):1287-1296.
Score: 0.055
-
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial. Heart. 2018 10; 104(19):1593-1599.
Score: 0.054
-
Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy). Am J Cardiol. 2018 04 01; 121(7):781-788.
Score: 0.054
-
Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy. J Am Coll Cardiol. 2017 Jun 13; 69(23):2794-2804.
Score: 0.051
-
Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2017 05 01; 2(5):490-497.
Score: 0.051
-
Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study. Circ Cardiovasc Interv. 2017 Mar; 10(3).
Score: 0.050
-
Women have a worse prognosis and undergo fewer coronary angiographies after out-of-hospital cardiac arrest than men. Eur Heart J Acute Cardiovasc Care. 2018 Aug; 7(5):414-422.
Score: 0.050
-
Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2017 01 09; 6(1).
Score: 0.050
-
Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI. JACC Cardiovasc Imaging. 2019 11; 12(11 Pt 1):2168-2178.
Score: 0.015
-
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study. Am Heart J. 2019 02; 208:37-46.
Score: 0.014
-
Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial. Clin Biochem. 2018 Sep; 59:37-42.
Score: 0.014
-
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization). Circ Cardiovasc Interv. 2017 Apr; 10(4).
Score: 0.013